X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2964) 2964
Book Review (493) 493
Publication (281) 281
Newsletter (35) 35
Newspaper Article (29) 29
Book Chapter (11) 11
Book / eBook (8) 8
Conference Proceeding (7) 7
Dissertation (7) 7
Magazine Article (7) 7
Web Resource (6) 6
Trade Publication Article (4) 4
Reference (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2480) 2480
humans (1882) 1882
methadone (1584) 1584
male (1279) 1279
female (1151) 1151
adult (832) 832
animals (827) 827
pharmacology & pharmacy (615) 615
methadone - therapeutic use (571) 571
methadone - pharmacology (513) 513
rats (471) 471
middle aged (449) 449
substance abuse (439) 439
buprenorphine (423) 423
morphine (389) 389
methadone - administration & dosage (379) 379
methadone - metabolism (376) 376
psychiatry (375) 375
pregnancy (374) 374
pharmacokinetics (352) 352
methadone hydrochloride (350) 350
opioids (350) 350
heroin (338) 338
drug interactions (315) 315
narcotics (304) 304
dose-response relationship, drug (289) 289
drug use (282) 282
methadone - adverse effects (267) 267
care and treatment (253) 253
metabolism (253) 253
methadone - pharmacokinetics (251) 251
neurosciences (248) 248
time factors (240) 240
drug abuse (236) 236
pain (230) 230
methadone - blood (223) 223
abridged index medicus (221) 221
opioid-related disorders - drug therapy (219) 219
analgesics, opioid - therapeutic use (217) 217
cocaine (213) 213
maintenance (210) 210
research (209) 209
morphine - pharmacology (208) 208
dependency (205) 205
opioid-related disorders - rehabilitation (205) 205
analysis (202) 202
article (199) 199
substance abuse treatment (199) 199
addiction (195) 195
toxicology (181) 181
drugs (174) 174
analgesics, opioid - administration & dosage (172) 172
opioid dependence (169) 169
central nervous system depressants (167) 167
pharmacology (165) 165
brain - metabolism (161) 161
narcotics - therapeutic use (161) 161
infant, newborn (159) 159
metabolites (158) 158
analgesics, opioid - adverse effects (156) 156
mice (155) 155
buprenorphine - therapeutic use (152) 152
kinetics (150) 150
pain - drug therapy (150) 150
young adult (149) 149
usa (147) 147
analgesics, opioid - pharmacology (145) 145
pharmacotherapy (145) 145
heroin dependence - rehabilitation (144) 144
drug therapy (141) 141
adolescent (139) 139
aged (138) 138
analgesics, opioid - pharmacokinetics (137) 137
health aspects (137) 137
maintenance treatment (137) 137
analgesics (133) 133
clinical neurology (133) 133
withdrawal (130) 130
dependence (128) 128
methadone-maintenance (128) 128
treatment outcome (125) 125
chemistry, analytical (124) 124
stereoisomerism (118) 118
in vitro techniques (117) 117
neonatal abstinence syndrome (116) 116
human liver-microsomes (115) 115
n-demethylation (113) 113
abuse (112) 112
naloxone - pharmacology (112) 112
medicine, general & internal (111) 111
administration, oral (110) 110
risk factors (109) 109
brain (107) 107
treatment (107) 107
dosage and administration (103) 103
pediatrics (103) 103
plasma (103) 103
patients (101) 101
narcotics - pharmacology (100) 100
methadone maintenance (99) 99
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3008) 3008
Spanish (20) 20
German (15) 15
French (11) 11
Polish (4) 4
Italian (3) 3
Norwegian (3) 3
Czech (2) 2
Japanese (2) 2
Danish (1) 1
Dutch (1) 1
Romanian (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Neuroscience, ISSN 0306-4522, 2010, Volume 167, Issue 3, pp. 880 - 893
Journal Article
Journal Article
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, ISSN 0363-6143, 06/2017, Volume 312, Issue 6, pp. C707 - C723
Fatty acids (including lubiprostone and cobiprostone) are human ClC-2 (hClC-2) Cl- channel activators. Molecular and cellular mechanisms underlying this... 
cobiprostone | DOMAIN | PHYSIOLOGY | fatty acids | lubiprostone | CELL BIOLOGY | TRANSMEMBRANE CONDUCTANCE REGULATOR | TIGHT JUNCTIONS | INHIBITION | ClC-2 activators | CHLORIDE CHANNEL | SECRETION | RECEPTORS | ClC-2 | PROSTAGLANDIN E-2 | CFTR | Receptors, Prostaglandin E, EP2 Subtype - metabolism | Prostaglandins - pharmacology | Triazoles - chemistry | Humans | Prostaglandins - chemistry | Arachidonic Acids - metabolism | Chlorides - metabolism | HEK293 Cells | Lubiprostone - pharmacology | Ion Transport | Cystic Fibrosis Transmembrane Conductance Regulator - deficiency | Binding Sites | Cyclic AMP - metabolism | Receptors, Prostaglandin E, EP4 Subtype - metabolism | Cyclic AMP-Dependent Protein Kinases - metabolism | Oleic Acid - metabolism | Chloride Channels - chemistry | Colforsin - pharmacology | Thiophenes - pharmacology | Cystic Fibrosis Transmembrane Conductance Regulator - metabolism | 1-Methyl-3-isobutylxanthine - pharmacology | Amino Acid Motifs | Chloride Channels - metabolism | Triazoles - pharmacology | Lubiprostone - chemistry | Protein Binding | Protein Kinase Inhibitors - pharmacology | Kinetics | Thiophenes - chemistry | Methadone - pharmacology | Protein kinase A | Medical research | Prostaglandin E2 | Cyclic AMP | Amino acids | Methadone | Chloride currents | Fatty acids | Dextran | Cellular biology | Oleic acid | Chlorides | Forskolin | Voltage | Index Medicus
Journal Article
Clinical Pharmacology in Drug Development, ISSN 2160-763X, 03/2017, Volume 6, Issue 2, pp. 125 - 134
Journal Article
Journal Article
Journal Article